Information About the Race to the CME Globe
The Race to the CME Globe is a season-long points competition in which LPGA Members accumulate points in every Official LPGA Tournament to gain entry into the season-ending CME Group Tour Championship. The player who wins the CME Group Tour Championship will be named the “Race to the CME Globe Champion.”
Starting in 2019, players will accumulate points at each official LPGA Tour event throughout the season leading up to the CME Group Tour Championship. The top 60 points earners and ties will then earn a spot in the CME Group Tour Championship, with the entire field competing for the $5 million purse and the $1.5 million winner’s check, the largest single prize in the history of women’s golf.
From 2014-2018, the top 72 players in the Race to the CME Globe competed in the CME Group Tour Championship, with the top 12 players mathematically eligible to win a $1 million bonus in 2017 and 2018. Past Race to the CME Globe champions are Lydia Ko (2014, 2015), Ariya Jutanugarn (2016, 2018) and Lexi Thompson (2017).
CME Group Cares Challenge - Score 1 For St. Jude
CME Group Cares Challenge- Score 1 for St. Jude is season-long charitable giving program that will turn each hole-in-one made on the LPGA Tour in 2019 into a donation. CME Group will donate $20,000 for each hole-in-one made on the LPGA Tour in 2020, with a minimum guaranteed donation of $500,000 to St. Jude Children's Research Hospital®, which is leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases. Proceeds from the program will help assure that families never receive a bill from St. Jude for treatment, travel, housing or food - because all a family should worry about is helping their child live.
There were no hole-in-ones at the 2020 Cambia Portland Classic. The 2020 season has seen seven aces, for a total of $140,000 donated to St. Jude Children’s Research Hospital.
The 2019 LPGA Tour season saw 32 aces from 31 different players, for a total of $620,000. This more than covers the average cost of $425,000 needed to treat a pediatric cancer patient.